Drug Interactions and the Cytochrome P450 System
- 32 Downloads
Cytochrome P450 1A2 (CYP1A2) accounts for about 10 to 15% of the total CYP content of human liver and is the major enzyme involved in the metabolism of imipramine, propranolol, clozapine, theophylline, and caffeine. It is also involved in the conversion of heterocyclic amines to their proximal carcinogenic and mutagenic forms, as well as in the metabolism of endogenous substances, including 17β-estradiol and uroporphyrinogen III. Fluvoxamine is a potent inhibitor of CYP1A2, and there is potential for interaction with drugs that are metabolised by this isoenzyme. This property of fluvoxamine may be usefully applied to identifying agents that are substrates of CYP1A2, and it has a possible therapeutic application in the prevention of CYP1A2-mediated toxic metabolite formation.
KeywordsTheophylline Clozapine Imipramine Fluvoxamine Phenacetin
Unable to display preview. Download preview PDF.
- 2.Eugster HP, Probst M, Wurgler FE, et al. Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae. Drug Metab Disp 1993; 21: 43–9Google Scholar
- 4.Spink DC, Eugster HP, Lincoln DW, et al. 17β-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch Biochem Biophys 1992; 293: 342–8PubMedCrossRefGoogle Scholar
- 10.Thomson AH, McGovern EM, Bennie P, et al. Interaction between fluvoxamine and theophylline. Pharm J 1992; 249: 137Google Scholar